Project Grant HT9425261E272
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $745K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai received a $591,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2027. The award supports research titled "Decoding the Tumor Microenvironment Remodeling of Cancer Vaccine Treatment in Pleural Mesothelioma," to be conducted at the institution's New York, NY location. This project...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai (ISMMS) received a $505,270 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025, with a completion date of September 29, 2027. The award supports research investigating the impact of reprogrammed PIK3R1-insulin-glucose metabolism pathway in lethal prostate cancer to develop therapeutic strategy. This research aligns with the...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a $507,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2027. The award supports research to investigate tumor-intrinsic epigenetic mechanisms that modulate antitumor immune responses in metastatic prostate cancer. This research initiative advances the DHA's mission to transform healthcare...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a $1.23M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2028. The award supports biomarker development research focused on refining an individualized risk-adapted approach to bladder-sparing treatment for muscle-invasive bladder cancer. This research initiative aims to advance clinical decision-making and...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $437,420 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Leveraging Personalized Stem Cell Therapy to Overcome Airway Reconstruction." The award was obligated on June 1, 2025, with a completion date of May 31, 2029, representing a four-year research initiative conducted at the institution's New York, NY...
- Federal Grant Award Summary The Defense Health Agency awarded Icahn School of Medicine at Mount Sinai a $1.25 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2026, through April 30, 2029, to develop first-in-class protein degraders targeting oncogenic PTK6 (Protein Tyrosine Kinase 6) in triple negative breast cancer. This three-year research initiative will be performed at the institution's New York, NY location and aims to advance...
- Grant Award Summary Icahn School of Medicine at Mount Sinai received a $633,750 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2028. The award funds research investigating the interplay between sensory neurons and natural killer (NK) cells during breast cancer metastatic dormancy. This research contributes to the DHA's broader mission of transforming healthcare for...
- Federal Project Grant Summary Icahn School of Medicine at Mount Sinai received a $633,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded August 1, 2025, with a completion date of July 31, 2028. The grant supports research investigating the interplay between sensory neurons and natural killer (NK) cells during breast cancer metastatic dormancy. This three-year research initiative aligns with the Defense Health...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai received a $3.3M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Leveraging Personalized Stem Cell Therapy to Overcome Airway Reconstruction." The four-year award, which commenced June 1, 2025 and concludes May 31, 2029, supports advanced biomedical research aimed at developing innovative therapeutic...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $2,065,452 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research titled "An Epigenetic Innate Immune Memory Hypothesis for Gulf War Illness: Development of a Pathophysiologically Based Diagnostic Biomarker Signature," which includes a fourth specific aim under...